Updates from The Motley Fool

Latest updates on Mast Therapeutics, Inc. from Fool.com.


Stock Performance

MSTX vs. S&P 500 | 2 Year Performance
MSTX 1-Day Stock Chart
MSTX 5-Day Stock Chart
MSTX 1-Month Stock Chart
MSTX 3-Month Stock Chart
MSTX 6-Month Stock Chart
MSTX 1-Year Stock Chart
MSTX 2-Year Stock Chart
MSTX 5-Year Stock Chart
View Interactive MSTX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Mast Therapeutics, Inc..
Current Price: $0.30
Prev Close: $0.30
Open: $0.29
Bid: $0.30
Ask: $0.30
Day's Range: $0.29 - $0.31
52wk Range: $0.21 - $0.60
Volume: 1,069,114
Avg Vol 1,476,355
Market Cap: $48.90M
P/E (ttm): -1.20
EPS (ttm): -$0.25
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Mast Therapeutics, Inc..
CAPS Rating 3 out of 5
 
112 Outperform
11 Underperform
CAPS All Stars
 
16 Outperform
3 Underperform

How do you think Mast Therapeutics, Inc. will perform against the market?



You pick for Mast Therapeutics, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Brian M. Culley, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Mast Therapeutics, Inc..

A biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers